StockData
Insulet Corp logo

Insulet Corp (PODD) stock

PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3048% below fair value
$145.34+0.05 (+0.03%)

Close on Nov 17, 2026Market cap $10.08BP/E 23.7Yield –

Insulet net income

Net income is the profit left for shareholders after every expense, interest and tax.

Insulet's net income for the twelve months ending Sep 30, 2026 was $428.80M, up 74.2% year over year. For fiscal 2025 it was $247.10M, down 40.9% from the year before. The highest annual figure on record is $418.30M in fiscal 2024.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$247.10M-40.9%
FY2024Dec 31, 2024$418.30M+102.8%
FY2023Dec 31, 2023$206.30M+4384.8%
FY2022Dec 31, 2022$4.60M-72.6%
FY2021Dec 31, 2021$16.80M+147.1%
FY2020Dec 31, 2020$6.80M-41.4%
FY2019Dec 31, 2019$11.60M+251.5%
FY2018Dec 31, 2018$3.30M–
FY2017Dec 31, 2017-$26.80M–
FY2016Dec 31, 2016-$28.88M–
FY2015Dec 31, 2015-$73.52M–
FY2014Dec 31, 2014-$51.50M–
FY2013Dec 31, 2013-$44.97M–
FY2012Dec 31, 2012-$51.87M–
FY2011Dec 31, 2011-$45.83M–
FY2010Dec 31, 2010-$61.16M–
FY2009Dec 31, 2009-$72.34M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$141.10M+61.1%
Q2 FY2026Jun 30, 2026$95.00M+322.2%
Q1 FY2026Mar 31, 2026$91.10M+157.3%
Q4 FY2025Dec 31, 2025$101.60M+0.9%
Q3 FY2025Sep 30, 2025$87.60M+13.0%
Q2 FY2025Jun 30, 2025$22.50M-88.1%
Q1 FY2025Mar 31, 2025$35.40M-31.3%
Q4 FY2024Dec 31, 2024$100.70M-2.5%
Q3 FY2024Sep 30, 2024$77.50M+49.3%
Q2 FY2024Jun 30, 2024$188.60M+590.8%
Q1 FY2024Mar 31, 2024$51.50M+116.4%
Q4 FY2023Dec 31, 2023$103.30M+507.6%
Q3 FY2023Sep 30, 2023$51.90M–
Q2 FY2023Jun 30, 2023$27.30M–
Q1 FY2023Mar 31, 2023$23.80M-14.4%
Q4 FY2022Dec 31, 2022$17.00M-41.8%
Q3 FY2022Sep 30, 2022-$5.20M-141.3%
Q2 FY2022Jun 30, 2022-$35.00M–
Q1 FY2022Mar 31, 2022$27.80M–
Q4 FY2021Dec 31, 2021$29.20M–
Q3 FY2021Sep 30, 2021$12.60M+8.6%
Q2 FY2021Jun 30, 2021-$25.00M-273.6%
Q1 FY2021Mar 31, 2021$0–
Q4 FY2020Dec 31, 2020-$17.10M-442.0%
Q3 FY2020Sep 30, 2020$11.60M+1350.0%
Q2 FY2020Jun 30, 2020$14.40M+928.6%
Q1 FY2020Mar 31, 2020-$2.10M-147.7%
Q4 FY2019Dec 31, 2019$5.00M-49.5%
Q3 FY2019Sep 30, 2019$800.00K-52.9%
Q2 FY2019Jun 30, 2019$1.40M–
Q1 FY2019Mar 31, 2019$4.40M–
Q4 FY2018Dec 31, 2018$9.90M–
Q3 FY2018Sep 30, 2018$1.70M–
Q2 FY2018Jun 30, 2018-$1.70M–
Q1 FY2018Mar 31, 2018-$6.60M–
Q4 FY2017Dec 31, 2017-$6.86M–
Q3 FY2017Sep 30, 2017-$2.23M–
Q2 FY2017Jun 30, 2017-$7.77M–
Q1 FY2017Mar 31, 2017-$9.98M–
Q4 FY2016Dec 31, 2016-$9.12M–

More Insulet figures

See a number that looks wrong?